Jennifer E Peel, Alyssa A Varghese, Reina N Paez, Sadhana Chauhan, Janice J Endsley, William S Lawrence
{"title":"Airborne Mycobacterium tuberculosis inactivated by advanced photohydrolysis technology.","authors":"Jennifer E Peel, Alyssa A Varghese, Reina N Paez, Sadhana Chauhan, Janice J Endsley, William S Lawrence","doi":"10.1186/s12941-026-00855-6","DOIUrl":null,"url":null,"abstract":"<p><p>Tuberculosis is a respiratory infectious disease that persists worldwide, largely due to the robustness and ease of dissemination of its causative agent, Mycobacterium tuberculosis. To mitigate the spread of infection, various measures have been developed to inactivate the bacteria in its aerosol form. Advanced photohydrolysis technology (APHT) was previously reported to inactivate both respiratory viral and bacterial pathogens; however, its efficacy against M. tuberculosis has yet to be evaluated. In this study, we assessed the ability of APHT to inactivate aerosolized M. tuberculosis. The bacteria were aerosolized into a custom chamber containing an APHT device, which was operated for 1 and 10 min after aerosolization. A control device lacking the APHT component was used for comparison. The APHT device achieved a 1.3-log<sub>10</sub> reduction (approximately 95%) in bacterial load after 1 min and a 2.26-log<sub>10</sub> reduction (over 99%) after 10 min. This study demonstrates the ability of APHT to inactivate aerosolized M. tuberculosis and supports its application as a possible effective infection control intervention.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13067662/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical Microbiology and Antimicrobials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12941-026-00855-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Tuberculosis is a respiratory infectious disease that persists worldwide, largely due to the robustness and ease of dissemination of its causative agent, Mycobacterium tuberculosis. To mitigate the spread of infection, various measures have been developed to inactivate the bacteria in its aerosol form. Advanced photohydrolysis technology (APHT) was previously reported to inactivate both respiratory viral and bacterial pathogens; however, its efficacy against M. tuberculosis has yet to be evaluated. In this study, we assessed the ability of APHT to inactivate aerosolized M. tuberculosis. The bacteria were aerosolized into a custom chamber containing an APHT device, which was operated for 1 and 10 min after aerosolization. A control device lacking the APHT component was used for comparison. The APHT device achieved a 1.3-log10 reduction (approximately 95%) in bacterial load after 1 min and a 2.26-log10 reduction (over 99%) after 10 min. This study demonstrates the ability of APHT to inactivate aerosolized M. tuberculosis and supports its application as a possible effective infection control intervention.
期刊介绍:
Annals of Clinical Microbiology and Antimicrobials considers good quality, novel and international research of more than regional relevance. Research must include epidemiological and/or clinical information about isolates, and the journal covers the clinical microbiology of bacteria, viruses and fungi, as well as antimicrobial treatment of infectious diseases.
Annals of Clinical Microbiology and Antimicrobials is an open access, peer-reviewed journal focusing on information concerning clinical microbiology, infectious diseases and antimicrobials. The management of infectious disease is dependent on correct diagnosis and appropriate antimicrobial treatment, and with this in mind, the journal aims to improve the communication between laboratory and clinical science in the field of clinical microbiology and antimicrobial treatment. Furthermore, the journal has no restrictions on space or access; this ensures that the journal can reach the widest possible audience.